By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS








Company News
Rexahn Pharmaceuticals, Inc. (RNN) To Participate In Brean Capital 2014 Life Sciences Summit 11/17/2014 12:25:47 PM
Rexahn Pharmaceuticals, Inc. (RNN) Reports Third Quarter 2014 Financial Results And Pipeline Update 11/13/2014 10:21:49 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The Stifel 2014 Healthcare Conference On November 18, 2014 11/11/2014 10:13:18 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BIO-Europe® Conference In Frankfurt, Germany 10/28/2014 7:43:17 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014 7:19:43 AM
Rexahn Pharmaceuticals, Inc. (RNN) Receives FDA Orphan Drug Designation For RX-3117 In Treatment Of Pancreatic Cancer 9/25/2014 7:51:44 AM
Rexahn Pharmaceuticals, Inc. (RNN)To Present At The 14th Annual Biotech In Europe Investor Forum For Global Partnering And Investment In Basel, Switzerland 9/23/2014 8:27:31 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BioPharm Americaâ„¢ 2014 In Boston, Massachusetts, USA 9/16/2014 11:26:15 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference On September 9, 2014 9/4/2014 10:42:14 AM
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014 8:41:13 AM
12345678910...
//-->